# Mediastinal NUT Carcinoma With Raised Serum Alpha-Fetoprotein Mimicking a Malignant Germ Cell Tumor: Suspicion Raised Due to Negative Serum miR-371a-3p Levels

**Authors:** Sheng-Yuan Kan, Cinzia G. Scarpini, Dawn Ward, Ben Fleming, Heok K. Cheow, Ibrahim Jalloh, John A. Tadross, James Watkins, Thomas Roberts, Jamie Trotman, Patrick Tarpey, Nicholas Coleman, C. Elizabeth Hook, Charlotte Burns, Claire Trayers, Matthew J. Murray

PMC · DOI: 10.1177/10935266251335391 · 2025-04-25

## TL;DR

A 15-year-old patient with a mediastinal tumor and high alpha-fetoprotein levels was diagnosed with NUT carcinoma after ruling out germ cell tumors using molecular tests and miRNA analysis.

## Contribution

The paper highlights the diagnostic utility of serum miR-371a-3p and agnostic molecular testing in distinguishing NUT carcinoma from germ cell tumors.

## Key findings

- Negative miR-371a-3p levels helped rule out malignant germ cell tumors.
- Whole genome and RNA sequencing confirmed a BRD4::NUTM1 gene fusion, diagnosing NUT carcinoma.
- NUTM1 immunohistochemistry confirmed the diagnosis after initial biopsy was non-diagnostic.

## Abstract

NUT carcinoma is challenging to diagnose and may mimic a germ cell tumor (GCT) due to raised serum alpha-fetoprotein (AFP). A 15-year-old patient presented with back pain and cough. Investigation revealed a mediastinal mass and multiple bone metastases. Serum AFP was highly elevated, consistent with a metastatic malignant nonseminomatous GCT. Aggressive chemotherapy was initiated with initial response, unfortunately not sustained. Diagnostic biopsy showed undifferentiated tumor cells with weak GCT immunophenotype but was ultimately non-diagnostic. Serum miR-371a-3p levels, highly sensitive/specific for malignant GCTs, were negative casting diagnostic suspicion. Routine use of agnostic molecular investigations, including whole genome sequencing, identified a chromosome 15:19 translocation, with BRD4::NUTM1 gene fusion on RNA sequencing, confirming NUT carcinoma. Subsequent NUTM1 immunohistochemistry was positive. A high index of clinical suspicion is required for non-pathologically/molecularly confirmed diagnoses. Serum miR-371a-3p quantification ruled out malignant GCT and routine agnostic molecular studies identified the correct diagnosis; a low threshold for NUTM1 immunohistochemistry is thus recommended.

## Linked entities

- **Genes:** BRD4 (bromodomain containing 4) [NCBI Gene 23476], NUTM1 (NUT midline carcinoma family member 1) [NCBI Gene 256646]
- **Diseases:** NUT carcinoma (MONDO:0005563), germ cell tumor (MONDO:0003751)

## Full-text entities

- **Genes:** AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}, NUTM1 (NUT midline carcinoma family member 1) [NCBI Gene 256646] {aka C15orf55, FAM22H, NUT}
- **Diseases:** GCT (MESH:D009373), NUT Carcinoma (MESH:D009369), mediastinal mass (MESH:D008477), undifferentiated tumor (MESH:D002277), cough (MESH:D003371), back pain (MESH:D001416), Mediastinal (MESH:D008480), bone metastases (MESH:D009362)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12241692/full.md

---
Source: https://tomesphere.com/paper/PMC12241692